• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Sanofi, AstraZeneca Report Promising RSV Pediatric Data Ahead of Pfizer Adcomm

cafead

Administrator
Staff member
  • cafead   May 12, 2023 at 10:22: AM
via New data from the Phase IIIb HARMONIE trial showed Sanofi’s and AstraZeneca’s respiratory syncytial virus antibody candidate nirsevimab exerts a strong protective effect in infants under 12 months, the companies announced Friday.

article source
 

<